A meta-analysis of red yeast rice: an effective and relatively safe alternative approach for dyslipidemia.
<h4>Objective</h4>To explore whether red yeast rice is a safe and effective alternative approach for dyslipidemia.<h4>Methods</h4>Pubmed, the Cochrane Library, EBSCO host, Chinese VIP Information (VIP), China National Knowledge Infrastructure (CNKI), Wanfang Databases were se...
Guardado en:
| Autores principales: | , , , , , , |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
Public Library of Science (PLoS)
2014
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/7806c0480add4e0388a54b30fe11f455 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| id |
oai:doaj.org-article:7806c0480add4e0388a54b30fe11f455 |
|---|---|
| record_format |
dspace |
| spelling |
oai:doaj.org-article:7806c0480add4e0388a54b30fe11f4552021-11-18T08:17:07ZA meta-analysis of red yeast rice: an effective and relatively safe alternative approach for dyslipidemia.1932-620310.1371/journal.pone.0098611https://doaj.org/article/7806c0480add4e0388a54b30fe11f4552014-01-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/24897342/?tool=EBIhttps://doaj.org/toc/1932-6203<h4>Objective</h4>To explore whether red yeast rice is a safe and effective alternative approach for dyslipidemia.<h4>Methods</h4>Pubmed, the Cochrane Library, EBSCO host, Chinese VIP Information (VIP), China National Knowledge Infrastructure (CNKI), Wanfang Databases were searched for appropriate articles. Randomized trials of RYR (not including Xuezhikang and Zhibituo) and placebo as control in patients with dyslipidemia were considered. Two authors read all papers and independently extracted all relevant information. The primary outcomes were serum total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), triglyceride (TG), and high-density lipoprotein cholesterol (HDL-C). The secondary outcomes were increased levels of alanine transaminase, aspartate aminotransferase, creatine kinase, creatinine and fasting blood glucose.<h4>Results</h4>A total of 13 randomized, placebo-controlled trials containing 804 participants were analyzed. Red yeast rice exhibited significant lowering effects on serum TC [WMD = -0.97 (95% CI: -1.13, -0.80) mmol/L, P<0.001], TG [WMD = -0.23 (95% CI: -0.31, -0.14) mmol/L, P<0.001], and LDL-C [WMD = -0.87 (95% CI: -1.03, -0.71) mmol/L, P<0.001] but no significant increasing effect on HDL-C [WMD = 0.08 (95% CI: -0.02, 0.19) mmol/L, P = 0.11] compared with placebo. No serious side effects were reported in all trials.<h4>Conclusions</h4>The meta-analysis suggests that red yeast rice is an effective and relatively safe approach for dyslipidemia. However, further long-term, rigorously designed randomized controlled trials are still warranted before red yeast rice could be recommended to patients with dyslipidemia, especially as an alternative to statins.Yinhua LiLong JiangZhangrong JiaWei XinShiwei YangQiu YangLuya WangPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 9, Iss 6, p e98611 (2014) |
| institution |
DOAJ |
| collection |
DOAJ |
| language |
EN |
| topic |
Medicine R Science Q |
| spellingShingle |
Medicine R Science Q Yinhua Li Long Jiang Zhangrong Jia Wei Xin Shiwei Yang Qiu Yang Luya Wang A meta-analysis of red yeast rice: an effective and relatively safe alternative approach for dyslipidemia. |
| description |
<h4>Objective</h4>To explore whether red yeast rice is a safe and effective alternative approach for dyslipidemia.<h4>Methods</h4>Pubmed, the Cochrane Library, EBSCO host, Chinese VIP Information (VIP), China National Knowledge Infrastructure (CNKI), Wanfang Databases were searched for appropriate articles. Randomized trials of RYR (not including Xuezhikang and Zhibituo) and placebo as control in patients with dyslipidemia were considered. Two authors read all papers and independently extracted all relevant information. The primary outcomes were serum total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), triglyceride (TG), and high-density lipoprotein cholesterol (HDL-C). The secondary outcomes were increased levels of alanine transaminase, aspartate aminotransferase, creatine kinase, creatinine and fasting blood glucose.<h4>Results</h4>A total of 13 randomized, placebo-controlled trials containing 804 participants were analyzed. Red yeast rice exhibited significant lowering effects on serum TC [WMD = -0.97 (95% CI: -1.13, -0.80) mmol/L, P<0.001], TG [WMD = -0.23 (95% CI: -0.31, -0.14) mmol/L, P<0.001], and LDL-C [WMD = -0.87 (95% CI: -1.03, -0.71) mmol/L, P<0.001] but no significant increasing effect on HDL-C [WMD = 0.08 (95% CI: -0.02, 0.19) mmol/L, P = 0.11] compared with placebo. No serious side effects were reported in all trials.<h4>Conclusions</h4>The meta-analysis suggests that red yeast rice is an effective and relatively safe approach for dyslipidemia. However, further long-term, rigorously designed randomized controlled trials are still warranted before red yeast rice could be recommended to patients with dyslipidemia, especially as an alternative to statins. |
| format |
article |
| author |
Yinhua Li Long Jiang Zhangrong Jia Wei Xin Shiwei Yang Qiu Yang Luya Wang |
| author_facet |
Yinhua Li Long Jiang Zhangrong Jia Wei Xin Shiwei Yang Qiu Yang Luya Wang |
| author_sort |
Yinhua Li |
| title |
A meta-analysis of red yeast rice: an effective and relatively safe alternative approach for dyslipidemia. |
| title_short |
A meta-analysis of red yeast rice: an effective and relatively safe alternative approach for dyslipidemia. |
| title_full |
A meta-analysis of red yeast rice: an effective and relatively safe alternative approach for dyslipidemia. |
| title_fullStr |
A meta-analysis of red yeast rice: an effective and relatively safe alternative approach for dyslipidemia. |
| title_full_unstemmed |
A meta-analysis of red yeast rice: an effective and relatively safe alternative approach for dyslipidemia. |
| title_sort |
meta-analysis of red yeast rice: an effective and relatively safe alternative approach for dyslipidemia. |
| publisher |
Public Library of Science (PLoS) |
| publishDate |
2014 |
| url |
https://doaj.org/article/7806c0480add4e0388a54b30fe11f455 |
| work_keys_str_mv |
AT yinhuali ametaanalysisofredyeastriceaneffectiveandrelativelysafealternativeapproachfordyslipidemia AT longjiang ametaanalysisofredyeastriceaneffectiveandrelativelysafealternativeapproachfordyslipidemia AT zhangrongjia ametaanalysisofredyeastriceaneffectiveandrelativelysafealternativeapproachfordyslipidemia AT weixin ametaanalysisofredyeastriceaneffectiveandrelativelysafealternativeapproachfordyslipidemia AT shiweiyang ametaanalysisofredyeastriceaneffectiveandrelativelysafealternativeapproachfordyslipidemia AT qiuyang ametaanalysisofredyeastriceaneffectiveandrelativelysafealternativeapproachfordyslipidemia AT luyawang ametaanalysisofredyeastriceaneffectiveandrelativelysafealternativeapproachfordyslipidemia AT yinhuali metaanalysisofredyeastriceaneffectiveandrelativelysafealternativeapproachfordyslipidemia AT longjiang metaanalysisofredyeastriceaneffectiveandrelativelysafealternativeapproachfordyslipidemia AT zhangrongjia metaanalysisofredyeastriceaneffectiveandrelativelysafealternativeapproachfordyslipidemia AT weixin metaanalysisofredyeastriceaneffectiveandrelativelysafealternativeapproachfordyslipidemia AT shiweiyang metaanalysisofredyeastriceaneffectiveandrelativelysafealternativeapproachfordyslipidemia AT qiuyang metaanalysisofredyeastriceaneffectiveandrelativelysafealternativeapproachfordyslipidemia AT luyawang metaanalysisofredyeastriceaneffectiveandrelativelysafealternativeapproachfordyslipidemia |
| _version_ |
1718421993584328704 |